Related Experiment Video
Updated: Oct 26, 2025

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
1.4K
Rapid Capture of Cancer Extracellular Vesicles by Lipid Patch Microarrays
Hui-Yu Liu1, Ravi Kumar1, Chunting Zhong1
1Institute of Nanotechnology (INT) & Karlsruhe Nano Micro Facility (KNMF), Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany.
Advanced Materials (Deerfield Beach, Fla.)
|July 26, 2021
Summary
A new method uses nanolithography to create lipid arrays for capturing cancer-specific extracellular vesicles (EVs) from blood. This technique enables rapid, sensitive detection of cancer biomarkers for liquid biopsy applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Cancer Diagnostics
Background:
- Extracellular vesicles (EVs) are crucial in cancer progression and can serve as biomarkers for liquid biopsy.
- Current methods for isolating cancer-associated EVs from biofluids are technically challenging and time-consuming.
Purpose of the Study:
- To develop a novel, rapid, and highly selective platform for capturing cancer-associated extracellular vesicles (EVs).
- To enable downstream analysis of the nucleic acid cargo within captured EVs for diagnostic purposes.
Main Methods:
- Utilized dip-pen nanolithography to generate microarrays of supported lipid membranes.
- Immobilized specific antibodies on lipid arrays to recognize and capture EV- and cancer-specific surface biomarkers.
- Demonstrated EV capture from patient serum samples without additional purification steps.
Main Results:
- Achieved highly selective and efficient capture of cancer-associated EVs using antibody-functionalized lipid microarrays.
- Confirmed retention of the nucleic acid cargo within captured EVs on the lipid array.
- Demonstrated the platform's feasibility for EV capture directly from patient sera, showing rapid capture, high specificity, and sensitivity with minimal sample volume.
Conclusions:
- The developed EV-capture platform offers a promising solution for efficient and sensitive detection of cancer-associated EVs.
- This technology facilitates liquid biopsy by enabling rapid isolation and potential downstream analysis of EV biomarkers.
- The platform's adaptability allows for the detection of various diagnostic EV targets by changing antibody specificities.

